Tech Company Financing Transactions
Harbinger Health Funding Round
Harbinger Health, operating out of Cambridge, received $140 million in funding from Flagship Pioneering, Partners Investment and Pictet.
Transaction Overview
Company Name
Announced On
9/28/2023
Transaction Type
Venture Equity
Amount
$140,000,000
Round
Series B
Investors
Proceeds Purpose
The company intends to use the funds for the completion of its Cancer ORigin Epigenetics-Harbinger Health (CORE-HH) 10,000-participant clinical study of its novel blood-based cancer screening platform, develop its two-tier testing model, expand its data science and commercial teams and capabilities, and initiate additional clinical studies in high-risk populations.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
25 Spinelli Place
Cambridge, MA 02138
USA
Cambridge, MA 02138
USA
Phone
Undisclosed
Website
Email Address
Overview
Harbinger Health is pioneering the detection of early cancer and enabling foundationally new approaches to cancer screening, diagnosis and management. Incubated within Flagship Pioneering for three years before launching in 2021, Harbinger combines advances in artificial intelligence with proprietary insights into the biology of the beginnings of cancer to identify cancer before it is visible or symptomatic with the aim of developing a low-cost, multi-cancer blood test.
Management Team
Title
Name
Email & Social
Browse more venture capital transactions:
Prev: 9/28/2023: The Grand World venture capital transaction
Next: 9/28/2023: Hydrexia venture capital transaction
Share this article
About Database of VC Transactions
We record every notable VC transaction. All VC database entries reported here are derived from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs